ROCHE INNOVATION CENTER COPENHAGEN A has a total of 12 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2007. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are WAVE LIFE SCIENCES LTD, SYNTHENA AG and TRIPLEX PHARMA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 12 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Special acyclic compounds | |
#6 | Peptides | |
#7 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Bleicher Konrad | 4 |
#2 | Hansen Dennis Jul | 4 |
#3 | Hansen Henrik Frydenlund | 3 |
#4 | Shu Xi | 3 |
#5 | Li Meiling | 3 |
#6 | Schaeublin Adrian | 3 |
#7 | Wu Yong | 3 |
#8 | Funder Erik | 3 |
#9 | Koch Troels | 3 |
#10 | Duschmale Joerg | 3 |
Publication | Filing date | Title |
---|---|---|
KR20200104302A | New thiophosphoramidite | |
KR20200104345A | Oligonucleotides Containing Phosphorodithioate Internucleoside Linkages | |
KR20190135494A | Orthogonal protecting groups for the preparation of stereoconstrained phosphorothioate oligonucleotides | |
KR20180073584A | Oligonucleotide joining method | |
KR20180136006A | Antisense oligomers and conjugates targeting pcsk9 |